E
Evoke Pharma, Inc. EVOK
$10.93 $0.020.18% NASDAQ
Recommendation
Prev Close
$10.91
Volume
23,847
Avg Vol (90D)
180,334
Market Cap
$23.53M
Dividend & Yield
--
52-Week Range
$1.94 - $10.92
P/E (TTM)
--
EPS (TTM)
-$1.92
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Halper Sadeh LLC Encourages EVOK, FSFG, BRY Shareholders to Contact the Firm to Discuss Their Rights
12/2/2025 - Globe Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger TRUE, BRY, EVOK, and FSFG
12/1/2025 - Globe Newswire
Financial Survey: Evoke Pharma (NASDAQ:EVOK) versus Assembly Biosciences (NASDAQ:ASMB)
11/22/2025 - Ticker Report
Halper Sadeh LLC Encourages AXTA, COMP, EVOK, JTAI Shareholders to Contact the Firm to Discuss Their Rights
11/18/2025 - PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger-COMP, HFWA, EVOK, and JTAI
11/18/2025 - PR Newswire
Evoke Pharma's Merger Uncertainty: Potential Risks to Business Operations and Financial Health
11/16/2025 - TipRanks Financial Blog
Halper Sadeh LLC Encourages JAMF, CIVI, EVOK Shareholders to Contact the Firm to Discuss Their Rights
11/14/2025 - Globe Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger-HBAN, AVDL, EVOK, and TRUE
11/13/2025 - PR Newswire
Evoke Pharma (EVOK) Achieves Significant Revenue Growth in Q3
11/13/2025 - GuruFocus
Evoke Pharma reports Q3 EPS (45c) vs (94c) last year
11/13/2025 - The Fly
Evoke Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update
11/13/2025 - GuruFocus
Evoke Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update
11/13/2025 - Globe Newswire
Evoke Pharma just downgraded at Laidlaw, here's why
11/6/2025 - The Fly
Halper Sadeh LLC Encourages DENN, EVOK, ODP Shareholders to Contact the Firm to Discuss Their Rights
11/6/2025 - Globe Newswire
Halper Sadeh LLC Encourages HBAN, FFWM, EVOK Shareholders to Contact the Firm to Discuss Their Rights
11/5/2025 - PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Evoke Pharma, ...
11/4/2025 - GuruFocus
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Evoke Pharma, Inc. (NASDAQ: EVOK)
11/4/2025 - Globe Newswire
Shareholder Alert: The Ademi Firm investigates whether Evoke Pharma Inc. ...
11/4/2025 - GuruFocus
Shareholder Alert: The Ademi Firm investigates whether Evoke Pharma Inc. is obtaining a Fair Price for its Public Shareholders
11/4/2025 - PR Newswire
EVOK Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Evoke Pharma, Inc. ...
11/4/2025 - GuruFocus
Evoke Pharma Rockets On Grabbing 140% Premium In Acquisition Deal
11/4/2025 - Benzinga
EVOK Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Evoke Pharma, Inc. is Fair to Shareholders
11/4/2025 - Business Wire
Evoke Pharma (EVOK) Soars Over 130% on Acquisition News
11/4/2025 - GuruFocus
Evoke Pharma soars on announcement to be acquired by QOL Medical
11/4/2025 - Seeking Alpha - Healthcare
QOL Medical to Acquire Evoke Pharma (EVOK) at Significant Premium
11/4/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$14.42M
EBITDA (TTM)
--
EBIT (TTM)
-$5.19M
Net Income (TTM)
-$5.23M
Balance Sheet
Total Assets (Q)
$15.65M
Total Debt (Q)
$5.11M
Total Liabilities (Q)
$12.29M
Book Value Per Share (Q)
$1.56
Cash Flow
Cash from Operations (TTM)
-$3.32M
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$3.56M
Net Change in Cash (TTM)
$237.00K
Filings
Filing Date
Thursday, November 13, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 9 and 13 (est)
Price History
Loading...
Beta
0.03
7-Day Total Return
2.44%
30-Day Total Return
130.59%
60-Day Total Return
111.21%
90-Day Total Return
150.69%
Year to Date Total Return
144.52%
1-Year Total Return
159.62%
2-Year Total Return
-34.47%
3-Year Total Return
-46.32%
5-Year Total Return
-97.54%
52-week Low
Apr 15, 2025 - $1.94
52-week High
Dec 02, 2025 - $10.92
Valuation
Market Cap
$23.53M - Nano Cap
Enterprise Value
$17.06M
Price/Sales (TTM)
1.93
Price/Book (Q)
7.00
Dividends and Shares
Shares Outstanding
2.56
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.evokepharma.com
Phone Number
858 345 1494
Address
420 Stevens Avenue
Solana Beach, CA 92075
Country
United States
Year Founded
2007
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases... more
NASDAQ 12/03/2025 4:00PM Eastern Quotes delayed